课题基金 / 基金详情

Studies on radiopharmaceuticals with mitochondria membrane potential dependent tumor accumulation

Studies on radiopharmaceuticals with mitochondria membrane potential dependent tumor accumulation
线粒体膜电位依赖性肿瘤蓄积放射性药物的研究
批准号:
17390330
负责人:
SAKAHARA Harumi
金额:
$6.1万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

SAKAHARA Harumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is well known that lipophilic cation radiopharmaceuticals such as T1-201 or Tc-99m-MIBI (MIBI) accumulate in some tumors and they are useful for tumor diagnosis. Both T1-201 and MIBI are currently used for myocardial blood flow scintigraphy. The uptake mechanism and kinetics in myocaridium cells have been reported to be different in these two radiopharmaceuticals. According to these reports, almost MIBI in the cells exist in the mitochondria fraction and the uptake of MIBI by myocardium cells depends on mitochondria membrane potential. Actually, the membrane potential of the myocardium is higher than that of other organs. In addition, the mitochondria membrane potential of some tumor cells is higher than that of normal cells_ It is expected that MIBI accumulates in the tumor cells depending on the membrane potential. On these basis, the uptake kinetics and patho-physiological studies of such cationic radiopharmaceuticals in the tumor cells was evaluated using in vitro cell culture e … More xperimental system in this research.First of all, we prepared some tumor cell lines for in vitro experiments. Relative mitochondria membrane potential of these cells was evaluated with JC-1 and a large variation of the membrane potential was indicated. In in vitro experiments, a high relationship between the membrane potential and MIBI uptake in the tumor cells was observed. In addition, similar relationship was shown in case of FDG. Because mitochondria membrane potential relates to the activity of energy metabolism, these results suggested that the uptake of both compounds can be used as index of the tumor cells activity. Next, we perforthed MIBI and FDG uptake studies in the tumor cells after photo dynamic therapy (PDT). About 50 % decrease per cell at 1-3 hours post PDT irradiation was observed in only MIBI uptake. It is suggested this phenomenon is derived from the alteration of mitochondria function because of apoptosis induced by PDT. This discrepancy between MIBI and FDG uptake interests us for diagnosis of tumor cell condition after therapy. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer
甲状腺癌患者放射性碘治疗后鼻泪管引流系统的可视化
DOI: --
发表时间: 2007
期刊: Ann Nucl Med 21(9)
影响因子: --
作者: [Sakahara, H., et. al.]
通讯作者: et. al.
Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer.
甲状腺癌患者放射性碘治疗后鼻泪管引流系统的可视化。
DOI: --
发表时间: 2007
期刊: Ann Nucl Med 21(9)
影响因子: --
作者: [宮部 結城, 山本 時裕, 矢野 慎輔, 手島 昭樹, 松本 政雄, 溝脇 尚志, 他, Sakahara H]
通讯作者: Sakahara H
DOI: 10.1097/mnm.0b013e32828d8cbc
发表时间: 2007-09
期刊: Nuclear Medicine Communications
影响因子: 1.5
作者: [Y. Kiyono;Y. Kuge;Yumiko Katada;H. Kawashima;Y. Magata;H. Saji]
通讯作者: Y. Kiyono;Y. Kuge;Yumiko Katada;H. Kawashima;Y. Magata;H. Saji
Visualization of hemodynamics in a silicon aneurysm model using time-resolved, 3D, phase-contrast MRI.
使用时间分辨 3D 相衬 MRI 可视化硅动脉瘤模型中的血流动力学。
DOI: --
发表时间: 2006
期刊: AJNR Am J Neuroradiol 27(5)
影响因子: --
作者: [Mizowaki, T, Isoda H]
通讯作者: Isoda H
9
    Search for new biomarker of anti-cancer drug effect using near-infrared diffuse optical spectroscopy targeting vasculature and hypoxia
    • 批准号:
      26282144
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.98万
    • 财政年份:
      2014
    • 负责人:
      SAKAHARA Harumi
    • 依托单位:
    Development of novel CT contrast agents with long retention in the vessel
    • 批准号:
      21390343
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.41万
    • 财政年份:
      2009
    • 负责人:
      SAKAHARA Harumi
    • 依托单位:
    Assessment of Tumor Proliferation after Anti-tumor Therapy by Thymidine Kinase 1 Activity with Nuclear Medicine Technique
    • 批准号:
      12470187
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2000
    • 负责人:
      SAKAHARA Harumi
    • 依托单位:
    海外基金